{"text": "  Daily Nation/ Thursday, September 11,2003\r\n                                                                                                 ~\"O\"'f\\:                                                                                                                        23\r\n  The sting in cheaper Aids drugs deal\r\n \u00b7Hidden agenda in                                                                                                           MEDICAL TECHNOLOGY\r\n WTO decision to\r\n relal patent rules                                                                                                                                                          ~rain surgery in\r\n  By Arthur Okwemba                                                                                                                                                          \"flder two hours\r\n             cheaper generics drugs for treating HIV/                                                                                                                           performed a two-hour operation to remove\r\n            he World Trade Organisation's decision\r\n  T          to allow developing countries to sidestep                                                                                                                          By making a simple incision under the upper\r\n             drug patents and manufacture or buy                                                                                                                                lip and into a patient's nose, doctors yesterday\r\n Aids and other diseases may not come that easily,                                                                                                                              tumours.\r\n after all.                                                                                                                                                                        The team of neuro-surgeons from Nairobi's\r\n    It is crafted in a way that it will benefit the very                                                                                                                        Aga Khan and Kenyatta National hospitals\r\n developed countries which have vehemently                                                                                                                                     \u00b7have performed brain surgeries on two needy\r\n opposed such an arrangement.                                                                                                                                                   neurosurgical patients selected from the latter\r\n    In the recent development, described as a \"mile-                                                                                                                          , hosp.i~k.' .\r\n stone\" in the Trade Related Intellectual Property                                                                                                                    The'opetation was performed at the Aga\r\n rights (Trips )issue, the patent protection on                                                                                                                    Khan Hospital in Nairobi by at<.lamof doctors\r\n cheaper drugs has been lifted.                                                                                                                                    from that institution and frOl)l,the,,(~err~i yc\r\n                                                                                                                                                                   Kenyatta National Hospital. Usiilg:ttr~\u00b7> '\\'\r\n     Also affected are diagnostic kits, especially for\r\n                                                                                                                                                                   transphinoidal approach, pituitaty'tq\"n,1d\"..l!!So'\u00b7\u00b7.,\r\n  HIV /Aids. Their prices are expected to fall as\r\n                                                                                                                                                                  were removed from below the bfam-w1tho:\u00bbt~\r\n  generic versions are developed.                                                                                                                                 opening up the head                    \",     ~~.-\r\n     This appears to mean developing countries can                                                                                                                    Dr Mohammed Qureishi, the Aga Khan's\r\n  do parallel importation of cheaper kits and anti-                                                                                                               medical director and chairman of the Neuro-\r\n  retroviral drugs for HIV/Aids or tuberculosis, dia-                                                                                                             logical Society of Kenya. led the team. He said\r\n  betes and malaria from countries like India and                                                                                                                 using the transphinoidal surgical method\r\n  Brazil without fear of litigation.                                                                                                                              greatlYW.luc.e~.the risk of epilepsy since no\r\n    Otherwise, countries with a pharmaceutical                                                                                                                    contact is m~'with the brain.\r\n capacity can, through what is called compulsory                                                                                                                      \"It is the safestapproach for a.brain surgery\r\n licensing, allow a company to manufacture a                                                                                                                      because we only handle the area around the\r\n generic version of a patented drug.                                                                                                                              tumour,\" he added; \"And it is less time-\r\n    They can then export or use them for domestic                                                                                                                consuming, but younb~dthe rig\\lt equip-\r\n consumption. With an estimated two million people                                                                                                               ment.\".,                          ;:i\u00b7:.\r\n infected with the HIV virus and with an increase in                                                                                                                 The surgeries were cOlldudeduriaerthe                  <\r\n TB and malaria cases, Kenya seems a definite bene-                                                                                                              five-year neurosurgery project betweenlbca};\r\n ficiary .                                                                                                                                                       neuro-surgeons and a team of self-sponsored\r\n    Initially, pharmaceutical companies opposed the                                                                                                              surgeons from St Louis, Missouri, US, who\r\n two processes, threatening to go to court if such sys-                                                                                                       . .were unable to come to Kenya this year.\r\n                                                                                                                                                              -\"'-<)';1'.Besurgeryandhospitalisation costs were\r\n tems were used. South Africa-based pharmaceuti-\r\n                                                                                                                                                                 met by .AgaKhan Hospital's annual welfare\r\ncal companies made good their threat and went to\r\n                                                                                                                                                                 budget, which is about Sh50 million. Such sur-\r\ncourt. However, they lost the case.                                                                                                    Photo/Fredrick Onyango    geries would cost between Sh300,OOO        and\r\n    Similarly contentious issues arose among WTO              Dr Mahmood Qureshi Cright), a neurosurgeon and the medical director at the Aga Khan Hos- Sh350,OOO a privl\\te hospital. At KNH, a\r\n                                                                                                                                                                               in\r\nmembers. The US insisted that countries which pro-            pital operates on a patient to remove a brain tumour. The patient had a two\u00b7hour operation         patient\"would have to chip iri Sh50,OOO     in\r\nduce generic versions of patent drugs should do so                                                                                                               addition to the Government's subsidy.\r\n                                                              yesterday as part of the hospital's annual neurosurgery project.\r\npurely for domestic consumption, and for a defined                                                                                                                            - By CLAY MUGANDA\r\nnumber of diseases.\r\n    Developing countries, Kenya included, opposed\r\nit, arguing this would bar them from exporting or\r\nimporting drugs from countries able to manufacture         trade facilitation, and transparency in government       provide adequate remuneration to the owner of the      .industries. And what we need is to find ways to\r\n                                                           procurement, which Europe and America want\r\ngenerics,.such as Brazil.                         .                                                                 patented drug.                                          transfer the technologies to us.\"\r\n                                                           developing countries to agree to negotiate in Can-\r\n    They also opposed limiting the scope of diseases                                                                   Besides this, patent experts argue that the US          The US has also ensured that if a country wants\r\n                                                           cun.\r\nto which these generics should apply.                                                                               and Europe are to benefit most from the system         to import a generic drug because it does not have\r\n                                                              Implementation of these issues, which African\r\n  Their argument, according to Kenyan trade                                                                         because their pharmaceutical companies dominate        the capacity to manufacture it 10caHr,-then it has to\r\n                                                           countries are uncomfortable with, will help devel-\r\nnegotiator at WTO, Nelson Ndirangu, the decisions                                                                   the developing countries.                              meet a number of other conditions as set out in the\r\n                                                           oped countries have greater access to markets on\r\nbe left to individual countries.                                                                                       Most of the pharmaceutical capacity in a country    Trips.\r\n                                                           the continent.                                           like Kenya belongs to multinational companies\r\n   Now, on the issue of exportation and importation                                                                                                                           Before using the system to import generic drugs,\r\n                                                             Some of Kenya and Uganda's trade negotiators\r\nof generic drugs, the US has agreed to the deal.                                                                    whose headquarters are in the capitals of these        a country has to notify the Trips council in advance.\r\n                                                           intimated that they were afraid the trade-off for the\r\n   But sources claim the Americans agreed only                                                                     superpowers.                                            It has to explain how it has established that it has\r\n                                                           drug deal might be dearer than what they are get-\r\nafter they ensured a language that protects their                                                                      So if Kenya decides to grant a compulsory licence   insufficient or no manufacturing capacity in its\r\n                                                           ting now.                                               to a pharmaceutical company to manufacture the\r\ninterests.                                                                                                                                                                 pharmaceutical sector of the drug it wants to\r\n                                                              In fact, according to Third World Network, an        drug, the inevitable beneficiaries will be these mul-   import.\r\n                                                           international NGO based in Malaysia, some Afri-         tinationals. '\r\nBargaining chip                                                                                                                                                               It will then specify the names and quantities of\r\n                                                           can countries were uncomfortable with the lan-              Says Lucas Sese, an Intellectual Property Man-\r\nTogether with their European counterparts, they                                                                                                                            the expected drugs, the names and addresses of the\r\n                                                           guage in the drug agreement and had to seek their       agement consultant: \"From the onset, American\r\nare said to be planning to use the deal as a bargain-                                                                                                                      company producing the drugs as well as the identity\r\n                                                           governments' approval before signing.                   pharmaceuticals would not refuse such a deal. For\r\ning chip during the Cancun meeting that started                                                                                                                            of the distributors.\r\n                                                              One of the conditions in the agreement is that a     they are going to sign something that would work in\r\nyesterday in Mexico.                                                                                                                                                          If a country like Kenya IS making the drugs for\r\n                                                           country that issues compulsory licences, such as        their interest.\r\n  There are four issues among them investment,             Kenya, will nor do it free of charge. It will have to     \"They control the world's major pharmaceutical                                CONTINUED     ON PAGE 24\r\n                                                                                                                                                                                                                     ...,\r\n                                                                                                                                                                                BRITISH AIRWAYS\r\n                                                                                                                                                 BA saver. One week only!\r\n                                                                                                                                                  From Wednesday Septem~r~             to Wednesday September\r\n                                                                                                                                                   17th, you can book a ticket from Nairobi to London for just $499.\r\n                                                                                                                                                  For more information. call British Airways on 32077400 or your\r\n                                                                                                                                                  favourite travel agent. Or book early at ba.com Whatever you do,\r\n                                                                                                                                                  do it fast. This unbelievably low price will not be available after\r\n                                                                                                                                                  Spm next Wednesday. Fare valid for travel from October 1st to\r\n                                                                                                                                                  De~ember 15th 2003. Ticket must be purchased on the day of\r\n                                                                                                                                                  reservation. Other terms and conditions apply;\r\n\u2022\u2022\u2022\u2022         )\r\nPage \f\r\n\r\n\r\n-------------------Trial Version-----------------------\r\n\r\nConvert PDF to Text Desktop Software.\r\n\r\nCopyright Convertpdftotext.net 2014.\r\n\r\nTo remove these lines, please activate your software from http://www.convertpdftotext.net/buynow.htm\r\n\r\n-------------------------------------------------------"}